Hepatocyte growth factor renders BRAF mutant human melanoma cell lines resistant to PLX4032 by downregulating the pro-apoptotic BH3-only proteins PUMA and BIM
Open Access
- 30 September 2016
- journal article
- research article
- Published by Springer Nature in Cell Death & Differentiation
- Vol. 23 (12) , 2054-2062
Abstract
Cell death and differentiation is a monthly research journal focused on the exciting field of programmed cell death and apoptosis. It provides a single accessible source of information for both scientists and clinicians, keeping them up-to-date with advances in the field. It encompasses programmed cell death, cell death induced by toxic agents, differentiation and the interrelation of these with cell proliferation.Keywords
This publication has 38 references indexed in Scilit:
- Control of apoptosis by the BCL-2 protein family: implications for physiology and therapyNature Reviews Molecular Cell Biology, 2013
- Impact of MET expression on outcome in BRAFV600E/K advanced melanomaHistopathology, 2013
- ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing plateletsNature Medicine, 2013
- Cytokine receptor signaling activates an IKK-dependent phosphorylation of PUMA to prevent cell deathCell Death & Differentiation, 2011
- Treatment of B-RAF mutant human tumor cells with a MEK inhibitor requires Bim and is enhanced by a BH3 mimeticJournal of Clinical Investigation, 2008
- Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activityProceedings of the National Academy of Sciences, 2008
- Gefitinib-Induced Killing of NSCLC Cell Lines Expressing Mutant EGFR Requires BIM and Can Be Enhanced by BH3 MimeticsPLOS Medicine, 2007
- Mutations of the BRAF gene in human cancerNature, 2002
- PUMA Induces the Rapid Apoptosis of Colorectal Cancer CellsMolecular Cell, 2001
- PUMA, a Novel Proapoptotic Gene, Is Induced by p53Molecular Cell, 2001